Skip to main content
GRCE logo

GRCE · Grace Therapeutics, Inc. · Holdings

Track GRCE — free
$2.08 +0.04 (+1.96%) At close · Oct 9
Market Cap
$43.75M
Shares
21.04M
Volume · Oct 9 37.8K Avg daily vol (3M) 170.3K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
Holders: 33
Total Value: $9,051,364
Total Shares: 3,987,392

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 33 13F filers · Δ vs Mar 31, 2026
Top Holder
21.3%
Sep 2024 → Jun 2026 · range 19.4% – 100.0%
+1.9 pts
Top 5
73.5%
Sep 2024 → Jun 2026 · range 73.5% – 100.0%
−0.3 pts
Top 10
90.5%
Sep 2024 → Jun 2026 · range 90.1% – 100.0%
+0.4 pts
HHI
1,265
Sep 2024 → Jun 2026 · range 1,237 – 10,000
Broadly held+28

Quarterly Activity

vs Mar 31, 2026
New
9
Increased
12
Decreased
5
Sold Out
11
Unchanged
7
Holder count: -2
Institutional value: -55.3%
Shares held: -8.9%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 36 of 36
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1444192 CUSIP 00439U104 Visit website Investor relations